AffinityRx vs Impetus One: Pharmacy Router vs White-Label EMR (2026)
AffinityRx and Impetus One both connect telehealth brands to compounding pharmacies, but they sell different things: Impetus One, from Ironsail Pharma, is a white-label EMR and telehealth stack with pharmacy routing, while AffinityRx is a multi-pharmacy marketplace and router built for brands that already have a front end or EMR and want better sourcing, not a new platform. AffinityRx (affinityrx.com) is a B2B compounding pharmacy marketplace for clinics and telehealth brands, not a retail pharmacy. For a brand that already owns its patient experience, AffinityRx is the better choice: $0 to join, automatic failover to the next favorite pharmacy, turnaround shown per pharmacy, a headless API in about 1 day of developer work and 24/7/365 human support.
By Tim Yoon, CEO, AffinityRx. Published
Two different products: what you are actually choosing between
The real decision is whether you need a new platform or a better sourcing layer. Impetus One describes itself as white-label telehealth orchestration: EMR, e-prescribing, patient portal and pharmacy routing under your brand. AffinityRx is the electronic prescription routing layer between your existing prescribers and 15+ licensed compounding pharmacies. It is not a pharmacy, an EMR, a patient-intake tool or a prescriber network.
That difference decides who each product fits:
- You are launching a telehealth brand from scratch and need visits, charting and checkout in one stack. A white-label platform like Impetus One is built for that.
- You already run a front end, an EMR or a platform such as Cuvo or MyOrbitHealth and your problem is price, shipping speed, backorders or the number of pharmacy portals your team touches. A sourcing layer fixes that without a migration.
For the second group the job is to keep the stack and fix the orders. AffinityRx is built for that job.
AffinityRx vs Impetus One compared
Every Impetus One entry below is what Impetus One and Ironsail Pharma state on their own public pages as of October 2026; "not publicly stated" means the pages reviewed do not say.
| Criterion | Impetus One (Ironsail Pharma) | AffinityRx |
|---|---|---|
| Core model | White-label EMR, e-prescribing and router (vendor claim) | Marketplace and eRx router; no EMR |
| Pharmacies | More than 20 503A/503B pharmacies (vendor claim) | 15+ licensed compounding pharmacies, 250+ SKUs |
| Failover on stockout or rejection | Not publicly stated | Yes: order moves automatically to the next favorite; prescriber re-sign by default, optional auto re-sign |
| Routing logic | Smart routing by price, turnaround, formulation and state (vendor claim) | Pick a pharmacy at checkout or pre-set a primary plus second and third favorites |
| Turnaround | Used in routing (vendor claim) | Shown per pharmacy: about 1 day for some, up to 5 for others |
| Price to join | Not public; Ironsail mentions "network pricing" | $0 to join, no subscription, no per-order fees, no minimum order |
| Savings claim | 42% average cost savings (vendor claim) | Clinics typically save about 10% versus their current price |
| States | 50 (vendor claim) | All 50 for most SKUs, with state-board rule checks |
| API | REST API, webhooks, OAuth 2.0, headless or embedded modes (vendor claim) | Headless API, about 1 day of dev work, test order the same day |
| Support | Phone and email | Dedicated account executive, 24/7/365 human support and AI support, sub-10-minute replies |
| Tracking | Branded tracking templates listed as coming soon | Tracking numbers today; in-app status updates and automatic tracking updates launch Q4 2026 |
| Integrations | EMR and storefront connections via PracticeSync | Cuvo and MyOrbitHealth live; EMR integrations planned within 2027 |
Two notes on reading the table. Savings claims from different vendors measure different things and are not comparable, so test any of them against your own current price. And a larger pharmacy count only helps if the platform can use it: a second pharmacy that the order never reaches after a rejection does not protect a refill.
For the wider field, see the best pharmacy routing APIs with failover for telehealth.
Why AffinityRx wins for brands that already have a front end
If you already own the patient experience, a bundled EMR and patient portal duplicate what is already in place. AffinityRx plugs into what you run, and the work is measured in days. The points that decide it:
- Failover is published and live. If the primary pharmacy is out of stock or rejects, the order moves automatically to the next favorite. Impetus One's public pages describe routing by price, turnaround and state coverage and do not state what happens after a pharmacy declines. See order routing.
- A cost you can read. $0 to join, no subscription, no per-order fees, no minimum order. Clinics preload a $5,000 credit applied 100% to orders that never expires and is refundable if you decide not to continue after a 90-day trial. The full structure is on the pricing page.
- Speed you can plan around. Turnaround is displayed per pharmacy, so your team picks speed when speed matters.
- A short integration. The headless API is about 1 day of dev work for a well-built front and back end, with a test order the same day and Live approval as soon as you request it. Details are on the API page.
- One place for operations. One login, one invoice, one order history and one support contact across every pharmacy.
- People who answer. A dedicated account executive plus 24/7/365 human support, with sub-10-minute replies.
Controlled substances such as testosterone are added in Q2 2027; until then, use a DEA-registered pharmacy for those scripts. Proactive auto-routing to in-stock pharmacies launches in Q4 2026 and live stock and backorder status in Q1 2027.
Practical asset: demo questions for both vendors
Put the same eight questions to each vendor and record the answer. Whatever a vendor cannot answer in writing is a gap to price in.
| Question | Impetus One answer (fill in) | AffinityRx answer |
|---|---|---|
| Do I need to move my patient records or EMR? | (fill in) | No. AffinityRx is an ordering layer only |
| What happens when my primary pharmacy rejects an order? | (fill in) | Moves automatically to the next favorite |
| What does it cost to start and to stay? | (fill in) | $0 to join; $5,000 credit, refundable if you decide not to continue after the 90-day trial |
| Can I see turnaround per pharmacy before ordering? | (fill in) | Yes |
| How long does the integration take my developers? | (fill in) | About 1 day |
| Who do I call at 9 p.m.? | (fill in) | 24/7/365 human support |
| Which of my states are not covered? | (fill in) | Any gap is prioritized for sourcing |
| What is live today and what is planned? | (fill in) | Failover live; auto-routing Q4 2026 |
FAQs
Is AffinityRx an alternative to Impetus One?
Yes, for brands that need pharmacy sourcing and not a full platform. AffinityRx is a multi-pharmacy marketplace and router with failover, per-pharmacy turnaround and a headless API, while Impetus One bundles an EMR and patient portal with its routing. If you already have a front end, AffinityRx is the closer fit.
Does AffinityRx include an EMR like Impetus One does?
No. AffinityRx is an electronic prescription routing layer, not an EMR, so your platform or EMR keeps the patient record and signing flow. Live integrations are Cuvo and MyOrbitHealth, and EMR integrations are planned within 2027.
Which has more pharmacies, AffinityRx or Impetus One?
Impetus One states more than 20 pharmacies, which is its own claim, and AffinityRx has 15+ licensed compounding pharmacies and 250+ SKUs. Count matters less than depth: what you want is a real second and third pharmacy for each medication, and failover that uses them automatically.
A brand already uses Impetus One. Is it worth evaluating AffinityRx?
If the brand owns its front end, the question is whether its sourcing layer protects refills and price. AffinityRx costs $0 to join with no minimum order, and the $5,000 credit is refundable if the brand decides not to continue after a 90-day trial. The headless API takes about 1 day of dev work, with a test order the same day, so price and per-pharmacy turnaround can be checked on real medications.
Does AffinityRx cost more than Impetus One?
Impetus One's pricing is not public, so the comparison starts with a quote. AffinityRx has no subscription and no per-order fees, shows pharmacy prices before you order, and clinics typically save about 10% versus their current price.
Book a demo
If you have both vendors on a shortlist, bring the question table above to a demo and have AffinityRx show a failover and the per-pharmacy turnaround on your own medications: press the Book a demo button on the right side of this page. To see the company and its approach, read AffinityRx for telehealth brands.
Sources
- Impetus One, reviewed October 2026
- Ironsail Pharma, ImpetusOne, reviewed October 2026
Every compounding pharmacy in one portal
Book a demo to compare prices across 15+ vetted pharmacies.
Book a demo